Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Allscripts Healthcare Solutions Trading Up 13.5 %
MDRX Stock traded up $2.08 during mid-day trading on Friday, hitting $17.53. 3,122,237 shares of the company were exchanged, compared to its average volume of 1,055,445. Allscripts Healthcare Solutions has a 12-month low of $13.05 and a 12-month high of $23.25. The firm has a market capitalization of $2.03 billion, a P/E ratio of 40.77, a PEG ratio of 1.41 and a beta of 1.02. The business has a fifty day simple moving average of $15.57 and a 200-day simple moving average of $18.82. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 0.28.
Allscripts Healthcare Solutions (NASDAQ:MDRX - Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The software maker reported $0.18 EPS for the quarter, topping the consensus estimate of $0.15 by $0.03. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.24%. The firm had revenue of $150.90 million for the quarter, compared to analyst estimates of $148.58 million. During the same period in the prior year, the business posted $0.17 EPS. The business's revenue for the quarter was up 6.9% compared to the same quarter last year. On average, equities research analysts predict that Allscripts Healthcare Solutions will post 0.67 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. StockNews.com downgraded Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating in a research report on Friday, May 13th. The Goldman Sachs Group initiated coverage on shares of Allscripts Healthcare Solutions in a report on Tuesday, July 12th. They issued a "neutral" rating and a $21.00 price objective for the company. Piper Sandler cut their price objective on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 in a research report on Thursday, June 9th. Finally, TheStreet lowered shares of Allscripts Healthcare Solutions from a "b" rating to a "c" rating in a report on Friday, May 6th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.
Insider Transactions at Allscripts Healthcare Solutions
In related news, Director Paul Black sold 60,000 shares of the stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the transaction, the director now owns 1,254,631 shares of the company's stock, valued at approximately $20,801,781.98. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Thomas Langan sold 51,537 shares of the company's stock in a transaction on Tuesday, May 10th. The stock was sold at an average price of $18.12, for a total transaction of $933,850.44. Following the sale, the insider now owns 139,912 shares of the company's stock, valued at $2,535,205.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul Black sold 60,000 shares of the stock in a transaction on Friday, June 10th. The shares were sold at an average price of $16.58, for a total value of $994,800.00. Following the completion of the sale, the director now owns 1,254,631 shares in the company, valued at $20,801,781.98. The disclosure for this sale can be found here. Insiders sold a total of 318,015 shares of company stock worth $5,550,054 over the last ninety days. Company insiders own 2.29% of the company's stock.
